Last update 23 Nov 2024

111In-ABY-002

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC)
Synonyms-
Target
HER2
Mechanism
HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
HER2 Positive Breast Cancer
Originator Organization
Affibody ABAffibody AB
Active Organization-
Inactive Organization
Zentralklinik Bad Berka GmbHZentralklinik Bad Berka GmbHAffibody ABAffibody AB
Drug Highest PhaseSuspendedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 111In-ABY-002
EUCTR2007-002530-11-SE / Not yet recruitingNot Applicable
An exploratory study to assess the distribution of 111In-ABY-002 tracer uptake for SPECT imaging in subjects with metastatic HER2-positive breast cancer
100 Clinical Results associated with 111In-ABY-002
Login to view more data
100 Translational Medicine associated with 111In-ABY-002
Login to view more data
100 Patents (Medical) associated with 111In-ABY-002
Login to view more data
100 Deals associated with 111In-ABY-002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HER2 Positive Breast CancerPhase 1
SE
Affibody ABAffibody AB
05 Jul 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free